Log In Get Started

News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Ingram Micro's controlling holder launched a 13.125 million-share secondary offering, sending the stock down about 3.8% in after-hours trading.
  • Constellation Brands will redeem $600 million of 4.35% senior notes due 2027 in cash on Sept. 18, reducing outstanding debt.
  • Blackstone initiated a sale process for ZO Skin Health, hiring advisors and valuing the brand at roughly $2 billion.
  • Assembly Biosciences elected a 40% U.S. profit-and-cost share on Gilead's HSV program, lifting its shares about 4.9% after-hours.
  • Gauzy announced a 1-for-20 reverse stock split effective Sept. 10, 2026 to meet Nasdaq's minimum bid-price requirement.
  • Russian MOEX rose 0.46% and Colombia's COLCAP hit a record close as oil, telecom and industrials led gains.
  • Paramount Skydance said California AG Rob Bonta's TV comments contradict his legal stance over a $1.88 billion bond in its merger dispute.

Latest Articles

Akari Therapeutics Reports Second Quarter 2026 Financial Results and Highlights Progress of AKTX-101 Towards Phase 1 and Strategic Collaboration for Its ADC Payload Platform
Aug 13, 2026
Avery Klein
Press Releases

Akari Therapeutics Reports Second Quarter 2026 Financial Results and Highlights Progress of AKTX-101 Towards Phase 1 and Strategic Collaboration for Its ADC Payload Platform

Akari Therapeutics reported robust Q2 2026 financials highlighted by $8.6 million in financing and progression of its lead antibody drug conjugate candidate, AKTX-101, towards a planned Phase 1 clinical trial in mid-2027. The company showcased compelling ASCO 2026 preclinical data demonstrating synergistic anti-tumor activity in KRAS-mutated pancre…

AKTX
Edesa Biotech Reports Fiscal 3rd Quarter 2026 Results
Aug 13, 2026
Maya Rios
Press Releases

Edesa Biotech Reports Fiscal 3rd Quarter 2026 Results

Edesa Biotech announced fiscal Q3 2026 results, highlighting readiness for its Phase 2 clinical trial of EB06 for vitiligo and positive exploratory analyses of paridiprubart in ARDS patients with acute kidney injury. The company is progressing in clinical execution and engaging strategic discussions for paridiprubart's late-stage development and co…

EDSA
KULR Technology Group Reports Second Quarter 2026 Financial Results
Aug 13, 2026
Ajmal Hussain
Press Releases

KULR Technology Group Reports Second Quarter 2026 Financial Results

KULR Technology Group announced its second quarter 2026 financial results, revealing a 43% revenue decline and a significant net loss of $21.97 million, primarily due to a non-cash $10.6 million fair value loss from its bitcoin holdings. The company is refocusing on its core energy platform, exiting bitcoin mining, repaying related debt, and reduci…

KULR
Xos Extends Gross Profit Streak, Highlighting Operational Efficiency
Aug 13, 2026
Marcus Reed
Press Releases

Xos Extends Gross Profit Streak, Highlighting Operational Efficiency

Xos, Inc. reported significant improvements in its first-half 2026 financials, expanding GAAP gross margin from 11.8% to 31.0% and non-GAAP gross margin from 4.9% to 29.0% year-over-year. The company reduced operating expenses by 8.6%, narrowed operating losses substantially, and improved EBITDA metrics while launching the new Power Hub energy stor…

XOS
Elutia Secures Up to $26 Million to Fund NXT-41x Through Commercial Launch; Reports Second Quarter 2026 Results
Aug 13, 2026
Sofia Navarro
Press Releases

Elutia Secures Up to $26 Million to Fund NXT-41x Through Commercial Launch; Reports Second Quarter 2026 Results

Elutia Inc. announced securing up to $26 million in funding to support the FDA clearance and full commercial launch of its antibiotic-eluting biomatrix product, NXT-41x, without issuing new equity. The company reported Q2 2026 financials showing a net loss of $7.6 million but progresses on regulatory and manufacturing milestones with strong surgeon…

ELUT
AmpliTech Group Reports Q2 2026 Revenue of $8.07 Million, up 50.9% Sequentially, and Gross Profit Growth of 161.2% Year-over-Year
Aug 13, 2026
Priya Menon
Press Releases

AmpliTech Group Reports Q2 2026 Revenue of $8.07 Million, up 50.9% Sequentially, and Gross Profit Growth of 161.2% Year-over-Year

AmpliTech Group, a US-based manufacturer of advanced RF and microwave components, announced Q2 2026 revenue of $8.07 million, up 50.9% sequentially, with gross profit increasing 161.2% YoY. The company invested heavily in R&D, especially in 5G and MMIC technologies, and strengthened its balance sheet with a successful Series A rights offering. It c…

AMPG
Martin Marietta Increases Quarterly Cash Dividend
Aug 13, 2026
Hana Yamamoto
Press Releases

Martin Marietta Increases Quarterly Cash Dividend

Martin Marietta Materials, Inc. has increased its quarterly cash dividend from $0.83 to $0.84 per share, marking its eleventh consecutive annual dividend raise. The dividend is payable on September 30, 2026, to shareholders of record as of September 1, 2026. The company highlights its strong cash flow, durable business model, and confidence in sust…

MLM
Celcuity Inc. Reports Release of Second Quarter 2026 Financial Results and Provides Corporate Update
Aug 13, 2026
Derek Hwang
Press Releases

Celcuity Inc. Reports Release of Second Quarter 2026 Financial Results and Provides Corporate Update

Celcuity Inc. reported second quarter 2026 financial results and corporate updates highlighting the FDA approval of REVTORPYK (gedatolisib) for HR+/HER2- PIK3CA wild-type advanced breast cancer, with commercial launch expected in Q3 2026. The company also announced positive Phase 3 VIKTORIA-1 trial results in the PIK3CA mutant cohort, supporting a …

CELC
Birchtech Reports Second Quarter 2026 Financial Results
Aug 13, 2026
Sofia Navarro
Press Releases

Birchtech Reports Second Quarter 2026 Financial Results

Birchtech Corp. reported its Q2 2026 financial results, highlighting increased revenues driven by stronger air business demand and inaugural water treatment sales. The company solidified its patent protections after all challenges to its patented SEA4 mercury emissions technology were dismissed. Despite revenue growth to $3.8 million, Birchtech po…

BCHT
Merlin, Inc. Reports Second Quarter 2026 Results
Aug 13, 2026
Marcus Reed
Press Releases

Merlin, Inc. Reports Second Quarter 2026 Results

Merlin, Inc. reported Q2 2026 results showing increased revenue and operating milestones in autonomous flight technology, including completion of a critical design review for USSOCOM's C-130J program, a first fully autonomous fixed-wing aircraft landing, and a strategic partnership with Israel Aerospace Industries. The company also progressed in ci…

MRLN
ROC Reports Second-Quarter 2026 Revenue Doubled Sequentially; Steady Government Contract Activity Delivers 41% YoY R&D Revenue Growth
Aug 13, 2026
Avery Klein
Press Releases

ROC Reports Second-Quarter 2026 Revenue Doubled Sequentially; Steady Government Contract Activity Delivers 41% YoY R&D Revenue Growth

Rank One Computing Corporation (ROC), a U.S.-based Vision AI leader, reported second-quarter 2026 financial results showing sequential revenue growth of nearly 100% to $5.1 million, driven by increased government R&D contracts and commercial traction across its Vision AI product portfolio. Government R&D revenues grew by 41% year-over-year, and ROC…

ROC
WidePoint Reports Second Quarter 2026 Financial Results
Aug 13, 2026
Avery Klein
Press Releases

WidePoint Reports Second Quarter 2026 Financial Results

WidePoint Corporation reported its second quarter 2026 financial results highlighting continued profitability with positive adjusted EBITDA for the 36th consecutive quarter and positive net income for the second consecutive quarter. The company was named the single awardee of the U.S. Department of Homeland Security (DHS) Cellular Wireless Managed …

WYY
dLocal Reports Second Quarter 2026 Financial Results
Aug 13, 2026
Hana Yamamoto
Press Releases

dLocal Reports Second Quarter 2026 Financial Results

dLocal delivered robust financial results for Q2 2026, reporting a 92% year-over-year increase in total payment volume (TPV) to nearly $18 billion and record gross profit of $127 million, up 29%. Operating profit rose 15% year-over-year to $64 million, with net income increasing 28% to $55 million. The company raised its TPV and gross profit guidan…

DLO
Mangoceuticals Inc.’s Merger Partner, Nuclea Energy, Inc., Enters into Definitive Agreement to Acquire Moltex Energy’s Advanced Nuclear Technology Assets
Aug 13, 2026
Nina Shah
Press Releases

Mangoceuticals Inc.’s Merger Partner, Nuclea Energy, Inc., Enters into Definitive Agreement to Acquire Moltex Energy’s Advanced Nuclear Technology Assets

Mangoceuticals' merger partner, Nuclea Energy, signed a definitive agreement to acquire Moltex Energy's advanced nuclear technology assets, including patents and technologies related to advanced reactors and nuclear fuel recycling. This acquisition is expected to broaden Nuclea's nuclear technology portfolio and provide strategic entry into multipl…

MGRX
Arcadia Biosciences (RKDA) Announces Second Quarter and First Half 2026 Financial Results and Business Highlights
Aug 13, 2026
Nina Shah
Press Releases

Arcadia Biosciences (RKDA) Announces Second Quarter and First Half 2026 Financial Results and Business Highlights

Arcadia Biosciences released its Q2 and first half 2026 financial results showing a modest decrease in revenues due to inventory and shipping delays but improved operating cash usage. The company raised $4 million via private placement and is poised for growth with new Zola product launches planned for late 2026 and early 2027. Despite operational …

RKDA